FOXO4-DRI — Indexed Studies

FOXO4-DRI regulates endothelial cell senescence via the P53 signaling pathway.

Hu Z, Li F, Hu C et al.

The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI.

Bourgeois B, Spreitzer E, Platero-Rochart D et al.

FOXO4-DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53-serine 15 phosphorylation.

Kong YX, Li ZS, Liu YB et al.

FOXO4-D-Retro-Inverso targets extracellular matrix production in fibroblasts and ameliorates bleomycin-induced pulmonary fibrosis in mice.

Liu Y, Hou Q, Wang R et al.

Eliminating Senescent Cells Can Promote Pulmonary Hypertension Development and Progression.

Born E, Lipskaia L, Breau M et al.

FOXO4 peptide targets myofibroblast ameliorates bleomycin-induced pulmonary fibrosis in mice through ECM-receptor interaction pathway.

Han X, Yuan T, Zhang J et al.

Targeting senescence-like fibroblasts radiosensitizes non-small cell lung cancer and reduces radiation-induced pulmonary fibrosis.

Meng J, Li Y, Wan C et al.

Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes.

Huang Y, He Y, Makarcyzk MJ et al.

Rejuvenation by Therapeutic Elimination of Senescent Cells.

Krimpenfort P, Berns A

Cellular senescence in the aging and diseased kidney.

Valentijn FA, Falke LL, Nguyen TQ et al.

[Molecular regulative mechanisms of aging and interventional effects of Chinese herbal medicine].

Liu BH, Gu YH, Tu Y et al.